DYN icon

Dyne Therapeutics

113 hedge funds and large institutions have $571M invested in Dyne Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

9% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% less capital invested

Capital invested by funds: $573M → $571M (-$1.79M)

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$860K
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$26.9M
2 +$10.8M
3 +$5.81M
4
Goldman Sachs
Goldman Sachs
New York
+$5.08M
5
Axa
Axa
France
+$4.27M

Top Sellers

1 -$19.5M
2 -$5.79M
3 -$2.24M
4
LGM
Logos Global Management
California
-$1.59M
5
Citigroup
Citigroup
New York
-$1.35M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$174K
77
$171K
78
$164K
79
$154K
80
$154K
81
$152K
82
$149K
83
$147K
84
$142K
85
$142K
86
$124K
87
$121K
88
$121K
89
$119K
90
$118K
91
$118K
92
$114K
93
$111K
94
$82.9K
95
$55K
96
$46K
97
$32.1K
98
$31.3K
99
$23.8K
100
$20.1K